Arbele is a biotech and biopharmaceutical company that has created proprietary discovery platforms to accelerate the development of multifunctional “first-in-class” immunotherapeutics. It's goal is to rapidly generate more effective, ‘combination' treatments for gastrointestinal cancers, including stomach, pancreas, colon, bile duct and liver, which are currently high mortality cancers with limited treatment options.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.